CLINICAL_TRIALS
trial_result
· 2025-05-29
Clinical Trial Update: MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas [Phase 1, Phase 2]
Summary
The study evaluates pembrolizumab in combination with MRI-guided laser ablation for recurrent malignant gliomas, with Phase 1/2 results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Malignant Glioma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-29